Disclosure obligations for trial participation, clinical use, and employer programs are separate from chemical detection
Sequence variants in RyR1, the skeletal muscle Ryanodine Receptor, correlate with intolerance to statins, but whether RyR1 can bind statins directly has remained unclear
The STEP 8 trial (published in JAMA, 2022) enrolled 338 adults with overweight or obesity, without type 2 diabetes, and randomised them to receive either semaglutide 2.4 mg weekly or liraglutide 3.0 mg daily for 68 weeks
If your compounded semaglutide includes additional ingredients, follow the compounding pharmacy specific instructions rather than the generic charts in this guide
Liraglutide achieved an 8% weight loss over 56 weeks (Pi-Sunyer et al., 2015), while semaglutide resulted in a 15% reduction over two years (Wharton et al., 2023)